Business Wire: First Ever Large-Scale Study Linking Nasal Anatomy to Allergy Symptoms, Unveiled at Leading Allergy, Asthma and Immunology Conference
First Ever Large-Scale Study Linking Nasal Anatomy to Allergy Symptoms, Unveiled at Leading Allergy, Asthma and Immunology Conference
New York Post: Nasal spray alternative to EpiPen for allergic reactions is approved by FDA
The U.S. Food and Drug Administration has approved ARS Pharmaceuticals' nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions. REUTERS The U.S. Food and ...
Nasal spray alternative to EpiPen for allergic reactions is approved by FDA
WCVB Channel 5 Boston: How a new nasal spray to treat severe allergic reaction works
NEW NASAL SPRAY, NOW APPROVED TO SAVE LIVES AFTER A SEVERE ALLERGIC REACTION. HERE TO TELL US MORE IS DOCTOR ALI RAJA, DEPUTY CHAIR OF THE DEPARTMENT OF EMERGENCY MEDICINE AT MASS GENERAL. DOCTOR RAJA ...
Healio: Thin film barrier more effective in seasonal allergic rhinitis than saline nasal spray
Thin film barrier more effective in seasonal allergic rhinitis than saline nasal spray
SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...
Seeking Alpha: Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA ...
Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in patients aged 6 years ...